Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.88 USD | -1.03% | -5.88% | +42.57% |
May. 10 | Leerink Partners Starts Aquestive Therapeutics With Outperform Rating, $8 Price Target | MT |
May. 08 | Transcript : Aquestive Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 |
Evolution of the average Target Price on Aquestive Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Aquestive Therapeutics, Inc.
Leerink Partners | |
Piper Sandler | |
Raymond James | |
HC Wainwright | |
JMP Securities | |
Wedbush | |
Alliance Global Partners | |
Oppenheimer | |
BMO Capital |
EPS Revisions
- Stock Market
- Equities
- AQST Stock
- Consensus Aquestive Therapeutics, Inc.